Evidence map›Paper›PMID 30394686›Full record

ArticleVeterinary medicine and science2019

Intratumoral temozolomide in spontaneous canine gliomas: feasibility of a novel therapy using implanted microcylinders.

Jill Hicks, Simon Platt, Georgina Stewart, Christine Senneca, Shannon Holmes, Marc Kent, Elizabeth Howerth, Jared Kaplan, Edward Kaplan

Abstract readClinical Trial, Veterinary
In one paragraph

Article in Veterinary medicine and science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jill HicksVeterinary Teaching Hospital, University of Georgia, Athens, Georgia, USA.ORCID 0000-0003-0977-7118
Simon PlattVeterinary Teaching Hospital, University of Georgia, Athens, Georgia, USA.
Georgina StewartVeterinary Teaching Hospital, University of Georgia, Athens, Georgia, USA.
Christine SennecaSmall Animal Hospital, University of Florida, Gainesville, FL, USA.
Shannon HolmesVeterinary Teaching Hospital, University of Georgia, Athens, Georgia, USA.
Marc KentVeterinary Teaching Hospital, University of Georgia, Athens, Georgia, USA.
Elizabeth HowerthVeterinary Teaching Hospital, University of Georgia, Athens, Georgia, USA.
Jared KaplanDepartment of Internal Medicine, Yale Medical School, New Haven, CT, USA.
Edward KaplanMicrospherix LLC, Bocan Raton, FL, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Entotherapy an image-guided drug-eluting microcylinder platform, has the potential to bypass the limitations of systemic chemotherapy use in the treatment of canine brain tumours. Gliomas, which are common in dogs and also represent the majority of fatal brain tumours in humans, can be amenable to chemotherapy with temozolomide. Biopolymer microcylinders conjugated with temozolomide and gadolinium were implanted into partially resected tumours of four client-owned dogs with gliomas. All four dogs presented with generalized seizures and had mild to no neurologic deficits at the time of craniotomy. All dogs underwent craniotomy for implantation of the microcylinders into partially resected gliomas (glioblastoma multiforme {n = 1} or oligodendroglioma {n = 3}). All dogs recovered well from the craniotomy and implantation procedure. This novel procedure appears to be feasible and tolerated in tumour-bearing dogs. A future controlled clinical study can now aim to evaluate the microcylinder implantation for long-term efficacy.

Indexed as

AnimalsAntineoplastic Agents, AlkylatingBrain NeoplasmsDog DiseasesDogsDrug ImplantsFemaleGliomaMaleTemozolomideAntineoplastic Agents, AlkylatingDrug ImplantsTemozolomidecaninechemotherapyentotherapygliomamagnetic resonance imaging

Identifiers

PMID30394686
PMCPMC6376143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.